文献速递胸部肿瘤放疗消化道肿瘤放疗放疗物理与技术

质子布拉格峰FLASH放疗中束斑序列优化用于OAR特异性剂量率控制的潜力与局限

Assessing the potential and pitfalls of spot sequence optimization for OAR-specific dose rate control in proton PBS Bragg peak FLASH radiotherapy.
PubMed 文献 · Radiother Oncol · 2025-11-19

该研究评估束流布置、最小监测单元(MMU)设置和解剖部位对布拉格峰FLASH放疗实现超高剂量率(UHDR)的影响。基于剂量率体积直方图(DRVH)构建目标函数,用启发式算法优化各感兴趣区剂量率分布,并在模体及8例淋巴结阴性非小细胞肺癌和5例肝癌患者计划中优化束斑投照序列。结果显示优化可提升肺和肝病例关键OAR的FLASH剂量率覆盖率,但获益受束流数、MMU约束和束斑分布影响,高MMU时改善有限。

要点

  • 束斑序列优化可提升肺和肝病例关键OAR的V40Gy/s覆盖率。
  • 3野布置在模体研究中显示更优的剂量率优化效果。
  • MMU为1200时优化带来的额外获益明显小于MMU为600时。

核心结论

  • 该方法成功优化了特定OAR的FLASH剂量率覆盖,在保持剂量学质量的同时提升布拉格峰FLASH效果。
  • 束斑序列优化的效果受束流数、MMU约束和束斑分布影响,显著提高FLASH比的能力有限。

研究设计与样本

  • 模体研究考察束流数对质子治疗计划优化性能的影响。
  • 连续8例淋巴结阴性非小细胞肺癌和5例肝癌患者计划先优化,再优化束斑投照序列以提升剂量率比。
  • 基于DRVH构建目标函数,将各ROI优化整合为多目标优化问题并用启发式算法求解。

主要发现

  • 模体研究表明束斑模式对剂量率的效果取决于束流数和束流布置,3野布置可获得更好的优化效果。
  • 肺病例MMU为600(喷嘴电流252nA)时,食管、心脏、脊髓和肺-GTV的平均剂量率(V40Gy/s)从38.3%、62.8%、59.6%和61.9%升至74.4%、85.5%、83.3%和78.6%(所有p值<0.001)。
  • 肺病例MMU为1200(喷嘴电流504nA)时,优化带来的获益不如MMU为600时明显。
  • 所有肝病例MMU为600时,食管、心脏、脊髓和肝-GTV的平均FLASH剂量率(V40Gy/s)从60.5%、52.7%、60.3%和59.1%升至75.1%、69.4%、80.2%和75.9%(所有p值<0.001)。
  • 肝病例MMU为1200时,四个OAR的V40Gy/s从约93.3%升至97.0%,仅显示有限的额外改善。

关键数值与推荐

  • FLASH剂量率覆盖通过剂量率体积直方图(DRVH)评估,并据此构建目标函数优化各ROI剂量率分布。

临床怎么用

  • 在质子布拉格峰FLASH放疗计划中可考虑优化束斑投照序列以提升关键OAR的FLASH剂量率覆盖。
  • 需结合束流数、MMU设置和解剖部位评估优化获益,高MMU时额外获益有限。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the impact of key treatment planning parameters-including beam arrangement, minimum monitor unit (MMU) settings, and anatomical site variability-on the ability to achieve ultra-high dose rate (UHDR) delivery in Bragg peak FLASH radiotherapy. METHODS: FLASH dose rate coverage can be assessed by dose-rate volume histogram (DRVH), thus objective functions based on DRVH can be constructed to optimize the dose rate distribution for individual regions of interest (ROIs). The optimization of each ROI, as part of the final objective function, is integrated into a multi-objective optimization problem that can be solved using a heuristic algorithm. A phantom-based study was conducted to investigate the effect of beam number on optimization performance in proton therapy planning. Treatment plans of 8 consecutive node-negative non-small cell lung cancer and 5 consecutive liver cancer patients were initially optimized, followed by optimizing the spot delivery sequence to enhance dose rate ratios without compromising dose performance. A thorough evaluation was conducted to assess the optimization of the scanning pattern in improving the FLASH ratio of critical OARs in Bragg peak FLASH-RT, considering beam currents, beam arrangement, MMU constraints, and anatomical sites in lung and liver cases. RESULTS: The phantom study demonstrated that the effectiveness of the spot pattern in dose rate depends on the number of beams and beam arrangement, and the 3-field arrangement can achieve better optimization effects. In lung cases, using a MMU of 600 (nozzle current of 252nA), scanning pattern optimization increased the average dose rate (V40Gy/s) for the esophagus, heart, spinal cord, and lung-GTV from 38.3 %, 62.8 %, 59.6 % and 61.9 % to 74.4 %, 85.5 %, 83.3 % and 78.6 %, respectively (all p-values < 0.001). When a higher MMU of 1200 (nozzle current of 504nA) was used, the benefits brought by optimization are not as obvious as the previous situation. For all liver cases with an MMU of 600, the average FLASH dose rate (V40Gy/s) for the esophagus, heart, spinal cord, and liver-GTV increased from 60.5 %, 52.7 %, 60.3 %, and 59.1 % to 75.1 %, 69.4 %, 80.2 %, and 75.9 %, respectively, after optimization (all p-values < 0.001). However, when a higher MMU of 1200 was used, the V40Gy/s for all four OARs increased from approximately 93.3 % to 97.0 %, showing only limited additional improvement. CONCLUSION: This approach successfully optimized FLASH dose rate coverage for specific OARs, enhancing BP-FLASH effectiveness by improving OAR protection while maintaining dosimetric quality. However, the impact of spot pattern optimization is influenced by factors such as the number of beams, MMU constraints, and spot distribution, with limited effectiveness in significantly increasing the FLASH ratio.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Diao L, Zhao X, Cheng C, et al. Assessing the potential and pitfalls of spot sequence optimization for OAR-specific dose rate control in proton PBS Bragg peak FLASH radiotherapy. Radiother Oncol. 2025. PMID: 41271173. doi:10.1016/j.radonc.2025.111291

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。